Second-line chemotherapy in advanced biliary cancer: a systematic review.

Authors
Lamarca, Angela
Hubner, Richard A
Ryder, W David J
Valle, Juan W
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK
Issue Date
2014-04-25

Metadata
Show full item record
Abstract
The randomized NCRN phase III ABC-02 trial provided level-A evidence for first-line chemotherapy with cisplatin and gemcitabine combination in advanced biliary cancer (ABC). This systematic literature review aims to evaluate the level of evidence for the use of second-line chemotherapy for patients with ABC in terms of overall survival, response, toxicity and quality of life.
Citation
Second-line chemotherapy in advanced biliary cancer: a systematic review. 2014: Ann Oncol
Journal
Annals of Oncology
URI
http://hdl.handle.net/10541/320663
DOI
10.1093/annonc/mdu162
PubMed ID
24769639
Type
Article
Language
en
ISSN
1569-8041
Collections